Increased government spending on and access to innovative medicines can help production by Turkey’s pharmaceutical industry soar from a value of $5 billion in 2011 to $23.3 billion by 2023, says a new report.
Read MoreAustralia’s federal government has begun a review of the “appropriateness” of the current extension arrangements for pharmaceutical patents.
Read MoreGreece has reportedly dropped plans to claw back revenues from the pharmaceutical industry as a way of covering the country’s outpatient drug overspend, which has already reached 250 million euros so far this year.
Read MoreNew research into levels of use across England of drugs which have been appraised by the National Institute for Health and Clinical Excellence (NICE) shows that, out of 13 treatments, such use appears to be higher than expected for six, and lower than expected for another six.
Read MoreThe Irish government has agreed a pricing deal with the pharmaceutical industry which is expected to yield savings to the state of more than 400 million euros over a three-year period.
Read More
